10.25.13
Following its recent 510(k) clearance by the U.S. Food and Drug Administration, Medtronic Inc. is launching the Export Advance aspiration catheter in the United States. The device
The device is the latest addition to Medtronic's portfolio of thrombectomy devices (technology that removes blood clots from coronary arteries). It features a pre-loaded stylet (a core wire that runs through the middle of the shaft to provide more support during delivery), which increases the deliverability and kink resistance of the new device while traversing the vasculature to reach the aspiration site.
To further optimize performance, according to the company, the Export Advance aspiration catheter is constructed with full-wall variable braiding technology, which provides variable degrees of stiffness along the length of the device to enhance flexibility and "pushability" while navigating the device through the vasculature.
"With the Export Advance aspiration catheter, Medtronic has taken the power and deliverability of manual thrombectomy devices to a new level," said Hoang Thai, M.D., an associate professor of medicine and associate program director of the interventional cardiology fellowship at the University of Arizona.
The Export Advance aspiration catheter received the CE mark in May and has been introduced in various international markets since then.
"With more than 10 years of market leadership in this product category, Medtronic has continued to lead the way in innovation, setting a new standard of performance with the Export Advance aspiration catheter," said Jason Weidman, vice president and general manager of Medtronic's coronary business. "In addition to superior deliverability, our next-generation device offers high-performing aspiration power that physicians have come to expect from Export aspiration catheters, which to date have been used to treat more than one million patients worldwide."
Medtronic is based in Minneapolis, Minn.
The device is the latest addition to Medtronic's portfolio of thrombectomy devices (technology that removes blood clots from coronary arteries). It features a pre-loaded stylet (a core wire that runs through the middle of the shaft to provide more support during delivery), which increases the deliverability and kink resistance of the new device while traversing the vasculature to reach the aspiration site.
To further optimize performance, according to the company, the Export Advance aspiration catheter is constructed with full-wall variable braiding technology, which provides variable degrees of stiffness along the length of the device to enhance flexibility and "pushability" while navigating the device through the vasculature.
"With the Export Advance aspiration catheter, Medtronic has taken the power and deliverability of manual thrombectomy devices to a new level," said Hoang Thai, M.D., an associate professor of medicine and associate program director of the interventional cardiology fellowship at the University of Arizona.
The Export Advance aspiration catheter received the CE mark in May and has been introduced in various international markets since then.
"With more than 10 years of market leadership in this product category, Medtronic has continued to lead the way in innovation, setting a new standard of performance with the Export Advance aspiration catheter," said Jason Weidman, vice president and general manager of Medtronic's coronary business. "In addition to superior deliverability, our next-generation device offers high-performing aspiration power that physicians have come to expect from Export aspiration catheters, which to date have been used to treat more than one million patients worldwide."
Medtronic is based in Minneapolis, Minn.